Melvin Churchill, MD
Rheumatology · Lincoln, NENPI 1710957311
Payments from drug & device makers
Across 1,959 payments — averaging $3686.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$1.7M
- Novartis$1.4M
- AbbVie$1.2M
- GSK$945K
- Gilead$637K
- Eli Lilly$630K
- plus $710K from 24 others
Across 19 payments — averaging $1718.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$13K
- Novartis$10K
- Pfizer$9K
- Gilead$84
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 593 | $1,700,740 |
| Novartis | 33 | $1,406,601 |
| AbbVie | 458 | $1,192,556 |
| GSK | 414 | $944,895 |
| Gilead | 112 | $637,078 |
| Eli Lilly | 37 | $629,949 |
| Pfizer | 84 | $318,183 |
| Navidea Biopharmaceuticals, Inc. | 6 | $146,206 |
| Noven Pharmaceuticals, Inc. | 29 | $86,833 |
| Regeneron | 34 | $80,812 |
| E.r. Squibb & Sons, L.L.C. | 14 | $46,195 |
| Amgen(2 entities) | 76 | $20,407 |
| Astrazeneca UK Limited | 1 | $4,060 |
| Lilly USA, LLC | 3 | $3,462 |
| CSL Behring | 1 | $2,168 |
| Aurinia Pharma U.S., Inc. | 18 | $314 |
| UCB, Inc. | 6 | $235 |
| ANI Pharmaceuticals, Inc. | 12 | $157 |
| Regeneron Healthcare Solutions, Inc. | 2 | $142 |
| Actelion Pharmaceuticals US, Inc. | 2 | $118 |
| Johnson & Johnson | 8 | $116 |
| Genentech, Inc. | 1 | $90 |
| Sanofi | 1 | $83 |
| Janssen Scientific Affairs, LLC | 2 | $82 |
| Genentech USA, Inc. | 3 | $51 |
| Bristol Myers Squibb | 3 | $48 |
| AstraZeneca | 2 | $41 |
| Karyopharm Therapeutics Inc. | 2 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $10 |
How this compares
$7,221,672 in reported general payments places this provider in the 95th percentile of 39 rheumatology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Lincoln
- Diana MeylerLincoln$12K
- Rick ChatwellLincoln$2K
- Rasha AlqadiLincoln$1K
- Mashood BadshahLincoln$461
- Amy GarwoodLincoln$251
- Jennifer ElliottLincoln$221
- Robert ValenteLincoln$173
- William PalmerOmaha$534K
- Ted MikulsOmaha$433K
- Abhijeet DanveOmaha$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.